Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Debrancher Deficiency”

11 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 11 results

Testing effectiveness (Phase 2)Ended earlyNCT04990388
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of UX053 in Patients With Glycogen Storage Disease Type III (GSD III)

Who this might be right for
Glycogen Storage Disease Type III
Ultragenyx Pharmaceutical Inc 9
Not applicableWithdrawnNCT02385162
What this trial is testing

Biomarker for Glycogen Storage Diseases (BioGlycogen)

Who this might be right for
Fructose Metabolism, Inborn ErrorsGlycogen Storage DiseaseGlycogen Storage Disease Type I+7 more
CENTOGENE GmbH Rostock
Not applicableStudy completedNCT04574830
What this trial is testing

Study to Evaluate Biomarkers and Clinical Manifestations in Individuals With Glycogen Storage Disease Type III (GSD III)

Who this might be right for
Glycogen Storage Disease Type III
Ultragenyx Pharmaceutical Inc 18
Not applicableLooking for participantsNCT07303140
What this trial is testing

Non-invasive Assessment of Liver Fibrosis in a French Cohort of Pediatric Patients With Type III Glycogen Storage Disease: Current State and Perspectives

Who this might be right for
Liver Fibrosis
University Hospital, Strasbourg, France 30
Testing effectiveness (Phase 2)Study completedNCT03642860
What this trial is testing

The Effect of Triheptanoin on Fatty Acid Oxidation and Exercise Tolerance in Patients With Glycogenoses

Who this might be right for
Tarui DiseaseDebrancher DeficiencyGYG1 DEFICIENCY
Rigshospitalet, Denmark 3
Not applicableLooking for participantsNCT06616545
What this trial is testing

French Observatory for Patients with Type 3 Glycogenosis

Who this might be right for
Glycogen Storage Disease Type III
Institut de Myologie, France 150
Not applicableUnknownNCT02635269
What this trial is testing

Fat and Sugar Metabolism During Exercise in Patients With Metabolic Myopathy

Who this might be right for
Metabolism, Inborn ErrorsLipid Metabolism, Inborn ErrorsCarbohydrate Metabolism, Inborn Errors+20 more
Rigshospitalet, Denmark 60
Not applicableUnknownNCT01563705
What this trial is testing

Prospective Follow-up of Patients With Glycogen Storage Disease Type III

Who this might be right for
Neuromuscular Disorders
Institut de Myologie, France 30
Not applicableStudy completedNCT02448667
What this trial is testing

Energy Supplements to Improve Exercise Tolerance in Metabolic Myopathies

Who this might be right for
Glycogen Storage Disease Type III
Rigshospitalet, Denmark 6
Not applicableEnded earlyNCT05196165
What this trial is testing

Clinical Survey Study to Assess Physical Function and the Incidence of Hypoglycemia in Participants With Glycogen Storage Disease Type III

Who this might be right for
Glycogen Storage Disease Type III
Ultragenyx Pharmaceutical Inc 14
Not applicableStudy completedNCT02054832
What this trial is testing

Sleep and Quality of Life in Patients With Glycogen Storage Disease on Standard Versus Modified Uncooked Cornstarch

Who this might be right for
Glycogen Storage Disease Type IAGlycogen Storage Disease Type IBGlycogen Storage Disease Type III+1 more
John Mitchell 11